Frontlight ResearchEarly access
Trial site
Centro Hospitalar Universitario Cova Da Beira E.P.E.
- 3running trials
- 4closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Atrial fibrillation2 trials
- Stroke2 trials
- Asthma1 trial
- Bronchiectasis1 trial
- Coronary artery disease1 trial
- Cystic fibrosis1 trial
- Phase
- Phase 35 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Completed4 trials
- Not yet recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Janssen Research & Development, LLC3 trials
- Bayer AG1 trial
- Inmunotek S.L.1 trial
- Shire1 trial
- UCB Biopharma SRL1 trial
Running trials
Recruiting
Recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Asthma1 recruiting
- Bronchiectasis1 recruiting
- Cystic fibrosis1 recruiting
Closed trials
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Active, not recruiting
Completed
Completed
A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)
Site data: EU CTIS (euclinicaltrials.eu)Updated 15 Nov 2026